Record First Quarter Sales
Q1 sales reached a record $669 million, up 9% year-over-year (prior year $615 million); organic sales up 7% driven by strong demand in Asia.
Robust Advanced Technology Solutions (ATS) Performance
ATS sales of $149 million, a 23% increase year-over-year (21% organic growth); segment EBITDA rose 43% to $33 million and margin improved to 22% driven by double-digit electronics dispense growth and recovering X-ray demand.
Profitability Records and Margin Resilience
Adjusted operating profit increased 10% to $166 million; EBITDA was a Q1 record of $203 million, up 8%, with consolidated EBITDA margin around 30% (in line with prior year). Adjusted EPS was a Q1 record of $2.37, up 15% from $2.06.
Strong Free Cash Flow and Capital Deployment
Free cash flow of $123 million in the quarter with cash conversion at 105% of net income (excluding non-cash gain). Company returned capital via $46 million dividends and $82 million share repurchases, while investing $18 million in capex.
Improved Guidance and Backlog Momentum
Backlog up ~4% year-over-year entering Q2. Q2 sales guidance $710–$740 million and adjusted EPS $2.70–$2.90. Full-year guidance raised to $2.86–$2.98 billion (midpoint +4.5%) and adjusted EPS $11–$11.60 (midpoint +10%).
Balance Sheet Strength and Leverage Management
Cash on hand $120 million, net debt ~$1.9 billion, and leverage ratio 2.1x (consistent with year-end targets). New credit facility provides ~ $800 million available capacity and financial flexibility for strategic M&A.
One-time Non-Cash Investment Gain Recognized Separately
A $22 million pre-tax non-cash mark-to-market gain from a minority investment (post-IPO) was recorded in other income and excluded from adjusted earnings.